Glicefar®

Solution for injection.

Central muscle relaxant.

Each mL of product contains:
Guaifenesin…………………………100 mg
Excipients q.s.c………………………1 mL

Adjuvant for induction of anesthesia in horses.
It can be used as an induction agent in combination with barbiturates to soften the induction and recovery stage of the latter. It can also be used in combination with other agents such as Xylazine and Ketamine, for the maintenance of anesthesia and thus decrease the concentration of inhalational anesthesia.

Horses.

• For use in combination with barbiturates, add the dose of barbiturates (e.g., thiopental) to the glycepar® solution prior to administration and proceed with the infusion, or administer as a bolus immediately after administration of glyceph®
• For use in combination with Xylazine and/or Ketamine, Xylazine is administered 2 to 5 minutes before, then Glycepfar® is administered at the recommended dose, and then Ketamine is administered, once signs of ataxia produced by Glycephar® are observed

Intravenous administration only.

• Dosage of the active ingredient: 100 – 110 mg of Guaifenesin/kg of body weight.
• Dosage of the product: 1 mL/kg body weight in single dose.

Do not use on horses whose meat is intended for human consumption.

• Do not administer Physostigmine or other anticholinesterase agents to horses receiving Guaifenesin.
• Do not administer to pregnant or lactating females.

In usual doses, adverse effects are transient and minor. Moderate decrease in blood pressure and increase in heart rate have been observed. Thromboebitis has also been reported after intravenous injection and perivascular administration may cause some tissue reaction. Hemolysis may occur in solutions with concentrations greater than 5%, but some sources indicate that this is negligible at concentrations of even 15%. Up to one liter of product can be administered with no toxic effects observed in the individual.

• The use of this product is recommended only in adult horses.
• Extravascular injection should be avoided as it can cause tissue irritation.
• It is recommended to monitor the patient’s heart and respiratory rate when Guaifenesin is administered.
• Keep out of reach of children and pets.

Do not handle by persons hypersensitive to Guaifenesin. In case of contact with skin, eyes or mucous membranes, wash immediately with plenty of water. In case of irritation, go to a medical center and show the product label. In case of accidental injection, go immediately to a medical center and show the product label.

Keep out of reach of children and pets.

Store at room temperature below 25°C. Do not refrigerate or freeze. Use immediately once opened and discard any excess product. For export: Store in a cool and dry place, at room temperature between 15 and 30 °C, protected from light.

Sale by prescription to the Veterinary Doctor.

VETERINARY USE

Chile: Reg. SAG N° 2039
Costa Rica: Reg. No. MV-6176
Peru: Reg. SENASA F.A0.01.I.0004
Imported and distributed by Representaciones Durand SAC.
Av. Manuel Olguín N° 501 Office N° 1006. Santiago de Surco, Lima – Peru.

Serum bottle with 500 mL

Laboratorio Drag Pharma Chile Invetec S.A.
Lautaro N° 300. Quilicura. Santiago. Chile.